CTChia Wei Teoh

Chia Wei Teoh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chia Wei Teoh has a total of 320 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Endovascular management of arteriovenous fistula postbiopsy of pediatric transplanted kidney using embolization with detachable coils

    by C. McDonnell, V.R. de Oliveira, C.W. Teoh, M.F. Dien Esquivel, A. McKay, A. Gasparetto, D.A. Parra

  • Open Access

    How Well Do “Dr. Google” and “Professor YouTube ” Answer Health Questions for Pediatric Kidney Transplant Recipients and Caregivers?

    by Ashley Burghall, Ryan R. D. Chan, Nicola Rosaasen, Tom D. Blydt‐Hansen, Laura Beresford, Allison Cammer, Keefe Davis, Kayla Flood, Aviva Goldberg, Lorraine Hamiwka, et al.

    Background: Pediatric kidney transplant recipients and their caregivers require comprehensive education to support self‐management. Increasingly, families supplement clinic teaching with online platforms such as Google and YouTube, yet the quality, readability, and usefulness of these resources are uncertain. Methods: Structured searches on Google and YouTube were conducted using patient‐style questions and medically oriented key terms across four prioritized topics: healthy eating, exercise, travel, and mental health. Resources were screened for relevance and assessed for accuracy, completeness (defined as including all key facts needed to support recommendations), readability, and actionability (defined as providing clear, practical steps users can follow). Two pediatric transplant healthcare providers independently reviewed each resource. Two researchers assessed understandability and actionability using the Patient Education Materials Assessment Tool (PEMAT), and readability using multiple readability tools. Results: Searches yielded 87 Google and 41 YouTube resources; most targeted adult transplant recipients. Healthcare providers assessed 65% of Google and 68% of YouTube resources to be accurate, but only 18% and 5% were factually complete. Actionable recommendations were identified in 42% (Google) and 29% (YouTube). Readability ranged from grade 5 to 17, with only 6 of 82 Google resources meeting the recommended grade 6 or lower. Mean understandability scores were 67% for both platforms. Actionability scores averaged 39% (Google) and 77% (YouTube). Resources suitable for pediatric audiences ( n = 28) had similar readability and understandability scores but slightly higher actionability (Google: 43%, YouTube: 81%). Most resources lacked pediatric focus, co‐creation, and practical guidance. Conclusions: Online searches generated limited high‐quality resources tailored to pediatric needs. Healthcare providers should guide families to vetted resources and consider co‐creating materials to improve relevance and impact.

  • Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis

    by Giorgio Trivioli, Marco Allinovi, Elio Di Marcantonio, Natasha A. Jawa, Antonella Trivelli, Jing Yang, Ryszard Grenda, Jacek Rubik, Aladdin J. Mohammad, Sara Testa, et al.

    Key Points: Among 72 patients with childhood-onset ANCA-associated vasculitis, kidney transplant survival was good (86%). ANCA-associated vasculitis relapse occurred in 8 patients (11%), a median of 71 months after transplantation and resulted in graft failure in only one case. Positive ANCA at the time of transplantation did not predict graft failure but was associated with a higher risk of relapse and worse graft function. Background: ANCA-associated vasculitis (AAV) is rare in children, and results in kidney failure in up to one third of cases. There is very limited knowledge on kidney transplantation in childhood-onset AAV. We assessed kidney transplantation outcomes and prognostic factors in a multicenter cohort of patients with childhood-onset AAV. Methods: Patients diagnosed with AAV during childhood (≤18 years) who received a kidney transplant were included in this retrospective study. We determined patient and graft survival, rates of chronic graft dysfunction (defined as eGFR 2 for ≥3 months) and AAV relapse, and assessed determinants of outcome with logistic regression models. Patients were matched 1:2 for age, sex, and era of transplantation with non-AAV recipients from the Hospital for Sick Children in Toronto, Canada, and their graft survival was compared. Results: We included 72 patients, of whom 53 (74%) had microscopic polyangiitis and 19 (26%) granulomatosis with polyangiitis. Their median age (interquartile range at the time of diagnosis and transplantation was 12 (9–14) and 14 (12–16) years, respectively. After a median post-transplant follow-up of 53 months (interquartile range, 25–97), 70 patients (97%) were alive, 62 (86%) had a functioning graft, 28 (39%) had developed chronic graft dysfunction, and 8 (11%) had experienced AAV relapse. Graft survival was comparable between AAV and non-AAV recipients. Acute rejection was the only independent predictor of graft failure (hazard ratio [HR], 12.11; 95% confidence interval [CI], 1.19 to 122.49). Positive ANCA at the time of transplantation was significantly associated with a chronic graft dysfunction (HR, 4.16; 95% CI, 1.71 to 10.13) and AAV relapse (HR, 23.1; 95% CI, 2.67 to 200.28). Conclusions: Patients with childhood-onset AAV show good overall and graft survival after kidney transplantation and a low rate of post-transplant relapse. Further studies are warranted to confirm whether positive ANCA at the time of transplantation is associated with poorer graft outcomes.


  • Challenges in Small Sample Size Cluster Trials for Medication Adherence: Insights From TAKE ‐ IT ‐ TOO

    by Spencer W. Riddell, Robert Platt, Mary Amanda Dew, Annette DeVito Dabbs, Vikas R. Dharnidharka, Bärbel Knäuper, Gillian Mayersohn, Chia Wei Teoh, Véronique Phan, Tom Blydt‐Hansen, et al.

    Cluster randomized controlled trials (CRTs) are valuable for interventions involving the clinical care team but often require larger sample sizes due to within‐cluster correlation and between‐cluster variability. The TAKE‐IT‐TOO pilot study aimed to estimate the intraclass correlation (ICC) necessary for designing a full‐scale CRT to improve medication adherence in pediatric kidney transplant recipients. We examined different approaches to summarizing electronically measured adherence and assessed how these choices impact ICC estimation and sample size requirements. In TAKE‐IT‐TOO, seven centers were randomized to either an adherence‐promoting intervention or a healthy‐living intervention. Medication adherence was tracked using electronic pillboxes over a 4‐week run‐in period followed by a 10‐week intervention. Variance estimates were calculated using generalized linear mixed models (GLMM) and used to derive ICC values. We compared two methods of summarizing adherence data and estimated the number of clusters and cluster sizes needed to detect an odds ratio of 1.5 between intervention groups across a range of plausible ICC values. The analysis demonstrated that using repeated adherence measures within each participant offered advantages over relying on a single summary measure, improving statistical power. However, large standard errors around variance estimates made precise ICC estimation difficult. Despite this, we identified a plausible range of ICC values and corresponding sample size requirements for future trials. The TAKE‐IT‐TOO study underscores the challenges of conducting CRTs in small populations and highlights the value of repeated outcome measures for maximizing statistical efficiency in adherence research.

  • Complications of paediatric kidney transplantation: a paediatrician’s review

    by Abeer Alessa, Atessa Bahadori, Elizabeth Dale, Armando J Lorenzo, Ashene McKay, Chia Wei Teoh, Nithiakishna Selvathesan

    Kidney transplantation is the preferred treatment for children with end-stage kidney disease, offering notable improvements in long-term survival and overall quality of life. Nonetheless, paediatric transplant recipients are susceptible to a spectrum of complications that compromise allograft function and overall health. This review highlights key post-transplant complications to aid general paediatricians in recognising and managing these challenges in concert with nephrologists. Early post-transplant complications include surgical issues and electrolyte abnormalities. Infectious complications are most frequent during the first year post-transplant and include viruses such as cytomegalovirus, Epstein-Barr virus and BK virus, as well as urinary tract infections and Pneumocystis jirovecii pneumonia. These infections are largely related to the degree of immunosuppression and require close monitoring. Cardiovascular and metabolic conditions, including hypertension, hyperlipidaemia and post-transplant diabetes mellitus, are also prevalent and contribute to long-term morbidity. These issues often stem from pre-existing kidney disease and ongoing immunosuppressive therapy. Allograft rejection, whether antibody-mediated or T cell-mediated, continues to be a major threat to graft survival. Early detection through donor-specific antibody screening and timely biopsy is essential for prompt intervention. Additional challenges include increased cancer risk, particularly post-transplant lymphoproliferative disorder, and recurrence of primary kidney disease. By recognising these complications early, general paediatricians play a crucial role in multidisciplinary care, improving graft survival and patient outcomes.


  • Challenging Clinical Practice Guideline Definitions in Childhood Nephrotic Syndrome

    by Cal H. Robinson, Nowrin Aman, Tonny H.M. Banh, Josefina Brooke, Vaneet Dhillon, Mackenzie Garner, Christoph Licht, Ashlene McKay, Rachel Pearl, Seetha Radhakrishnan, et al.

    Key Points: Three quarters of children with steroid-resistant nephrotic syndrome respond to other immunosuppression and have good kidney outcomes. Children classified as frequently relapsing by International Pediatric Nephrology Association versus Kidney Disease Improving Global Outcomes criteria have similar relapse rates and risk of CKD. These findings support defining treatment resistance by response to any immunosuppression and implementing the International Pediatric Nephrology Association criteria for frequent relapses. Background: In childhood nephrotic syndrome, definitions of immunosuppression response, frequently relapsing nephrotic syndrome (FRNS), and long-term remission are conflicting and based on limited evidence. Our goal was to define treatment response, FRNS, and long-term remission on the basis of associated disease outcomes. Methods: We included children (6 months–18 years) diagnosed with nephrotic syndrome between 1993 and 2023 in combined Canadian cohorts. We evaluated different definitions of ( 1 ) immunosuppressive treatment response, ( 2 ) FRNS, including Kidney Disease Improving Global Outcomes (KDIGO) 2021 and International Pediatric Nephrology Association (IPNA) 2023 criteria, and ( 3 ) long-term remission. Outcomes were time to CKD, relapse count throughout follow-up, and time to relapse, analyzed by Cox proportional hazards and negative binomial regression. Results: We included 1114 children with nephrotic syndrome (median age at diagnosis, 3.8 years; 63% male; median follow-up, 4.7 years). Among them, 1054 (95%) were steroid sensitive, 60 (5%) were steroid resistant (steroid-resistant nephrotic syndrome [SRNS]), and 73% with SRNS achieved complete remission with steroid-sparing immunosuppression. No child with treatment-responsive SRNS developed CKD. Within 1 year of diagnosis, 281 steroid-sensitive children (27%) were classified with FRNS by KDIGO and 383 (36%) by IPNA criteria. Children with FRNS by IPNA criteria (versus KDIGO) had a similar number of relapses (adjusted rate ratio, 0.95; 95% confidence interval, 0.81 to 1.12) and CKD risk (2% each) but less often received steroid-sparing immunosuppression (hazard ratio, 0.42; 95% confidence interval, 0.32 to 0.56). Ninety-eight percent of relapses occur within 3 years of the initial diagnosis or the last relapse event. Conclusions: Children with SRNS who achieve remission have a similar CKD risk to steroid-sensitive children. Children with FRNS by IPNA 2023 and KDIGO 2021 criteria experience similar rates of relapse and CKD. This supports defining treatment resistance by response to any immunosuppressive medication, implementation of the IPNA FRNS criteria, and use of 3-year relapse-free survival as a surrogate for long-term remission.


  • Routine Doppler Ultrasonography Does Not Differentiate Acute Tubular Necrosis and Rejection in Early Pediatric Kidney Transplantation

    by Ihtisham Ahmad, Priyank Yadav, Dheidan Alshammari, Adree Khondker, Joana Dos Santos, Mandy Rickard, Jin Kyu Kim, Chia Wei Teoh, Ashlene McKay, Nithiakishna Selvathesan, et al.

    Introduction: Differentiating acute tubular necrosis (ATN) from rejection in pediatric kidney transplant (KT) recipients remains challenging and necessitates invasive biopsy. Doppler ultrasound‐derived resistive index (RI) is a noninvasive modality to assess graft status, but its diagnostic utility in children is unclear. This study evaluates RI's ability to distinguish ATN and rejection in KT. Methods: In this retrospective cohort (2000–2021), 296 pediatric KT recipients with surveillance or clinically indicated biopsies were categorized into uncomplicated ( n = 164), ATN ( n = 65), or rejection ( n = 67) groups. RI was measured at 24 h, 3, 6, and 12 months post‐KT. Linear mixed‐effects models assessed temporal trends and associations with complications. Results: Baseline demographics were similar between groups ( p > 0.05), but significant differences were observed in cold ischemia time ( p = 0.019), time to complication ( p < 0.001), and lower graft function in complicated groups ( p < 0.001 and p = 0.002). Median RI did not differ between groups in surveillance ( p > 0.05) or clinically indicated biopsies ( p > 0.05). Established RI thresholds of 0.7 and 0.8 lacked specificity ( p > 0.05). In a multivariate model, RI increased temporally posttransplant (3 months: +0.04, p < 0.001; 1 year: +0.05, p < 0.001), inversely correlated with recipient age ( p < 0.001), and marginally with donor kidney size ( p = 0.009), but showed no association with complications ( p > 0.05). Conclusion: RI thresholds and trends do not differentiate ATN and rejection in pediatric KT. Temporal RI rise likely reflects systemic hemodynamic adaptation rather than pathology, limiting its standalone diagnostic utility. Future studies should integrate multimodal approaches with RI, clinical, and biochemical markers to refine noninvasive strategies.


  • Overweight and Obesity in Pediatric Kidney Transplant Recipients Are Not Associated With Higher Risks of Early Postoperative Complications

    by Juliane Richter, Fabian Doktor, Mandy Rickard, Joana Dos Santos, Priyank Yadav, Chia Wei Teoh, Ashlene McKay, Jin K. Kim, Michael E. Chua, Armando J. Lorenzo

    Background: Childhood overweight and obesity have been hypothesized to pose challenges in pediatric kidney transplantation due to potential complications and resultant worse outcomes. Herein, we aimed to determine if pediatric patients with an elevated body mass index (BMI) (> 85th percentile) are at higher risk for short‐term complications following kidney transplantation. Methods: Following a review of our transplant database (2010–2020), patients > 2–18 years were assigned to groups based on BMI percentiles at the time of surgery: normal (5th–85th percentile; n = 120) and obese/overweight (> 85th percentile; n = 60). Patients were matched using a 1‐to‐2‐ratio nearest‐neighbor propensity score matching adjusting for underlying diagnosis, sex, and age. The primary outcome was postoperative complications classified according to Clavien‐Dindo, and secondary outcomes included postoperative creatinine and kidney graft rejection. Results: One hundred eighty patients ( n = 120 in the control and n = 60 in the overweight and obese group) were included. There was no significant difference in postoperative complications (72/120 vs. 40/60, p = 0.42). We noted no difference in nadir creatinine (7 days, [interquartile range (IQR) 1, 679] and 9 days, [IQR 1, 690], p = 0.11), postoperative creatinine levels at 3‐, 6‐, and 12‐months post‐transplantation, or rejection rates (8.4% and 8.4%, p > 0.99) between normal weighed and obese/overweight patients. However, more overweight and obese patients required intraoperative blood transfusions (55% and 33.4%, p = 0.006) and longer hospital stays (18.0 [IQR 9, 133] and 15.0 [IQR 7, 49], p = 0.02). Conclusions: It appears as though overweight and obese pediatric kidney transplant patients do not experience more postoperative complications. We propose that overweight and obesity should not be considered criteria to exclude pediatric patients from undergoing kidney transplantations.


  • Response to Shen and Li

    by Paul C Nathan, Cindy Lau, Vicky L Ng, Mar Miserachs, Chia Wei Teoh, Melinda Solomon, Anne I Dipchand, Maria Locke, Sumit Gupta

  • Longitudinal medication adherence in children with nephrotic syndrome and association with disease outcomes

    by Cal Robinson, Nowrin Aman, Harshita Arora, Tonny H M Banh, Josefina Brooke, Vaneet Dhillon, Mackenzie Garner, Christoph Licht, Ashlene McKay, Sruti Prabakaran, et al.

    Background: Children with nephrotic syndrome have a high medication burden and treatment-related side effects, which can contribute to non-adherence. Optimal medication adherence may reduce symptom burden, improve disease control and prevent complications. However, longitudinal patterns of medication adherence and associations with disease outcomes among children with nephrotic syndrome remain uncertain. Methods: We analysed data from Insight into Nephrotic Syndrome: Investigating Genes, Health, and Therapeutics, a prospective observational childhood nephrotic syndrome cohort. We included all children (1–18 years of age) with nephrotic syndrome diagnosed from 1996 to 2023 from the Greater Toronto and Hamilton Area, Canada, excluding congenital or secondary causes of nephrotic syndrome. Participants were followed annually with questionnaires for up to 5 years since study initiation. Medication adherence was self-reported by participants or parents using the Medication Adherence Questionnaire (MAQ). We evaluated the association between longitudinal medication non-adherence (MAQ score ≥1) and subsequent relapse rates, steroid-sparing medication initiation and hospitalizations using generalized linear mixed models. Results: We included 1905 study visits among 735 children diagnosed with nephrotic syndrome [mean age at visit 8.7 years (standard deviation 4.3), 65% male, 30% frequently relapsing or steroid dependent, median 1 (interquartile range 0–3) prescribed medications]. Medication non-adherence (MAQ score ≥1) was reported at 367 (19%) study visits and 228 (31%) participants reported non-adherence at least once. Rates of non-adherence remained stable over 5 years of follow-up. Worse medication adherence was not significantly associated with subsequent relapse rates {adjusted relative rate 1.14 [95% confidence interval (CI) 0.97–1.34]}, use of steroid-sparing medication [adjusted odds ratio (OR) 0.90 (95% CI 0.61–1.32] or rituximab [adjusted OR 0.77 (95% CI 0.36–1.66)] or hospitalizations [adjusted OR 1.17 (95% CI 0.59–2.32)]. Conclusions: Self-reported medication non-adherence occurs in one-third of children with nephrotic syndrome yet does not adversely affect subsequent relapses, steroid-sparing medication use or hospitalizations.